menu
    • menu

    Company profile for Allysta Pharmaceuticals

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Allysta Pharmaceuticals is a private clinical stage biopharmaceutical company based in the San Francisco Bay Area. We are developing first-in-class therapeutic peptides that uniquely target adiponectin signaling pathways. Adiponectin, a natural protein whose receptors are widely distributed, has multiple beneficial actions, including anti-inflammatory, anti-fibrotic, anti-steatotic, and cell regenerative properties; it also pl...
    Allysta Pharmaceuticals is a private clinical stage biopharmaceutical company based in the San Francisco Bay Area. We are developing first-in-class therapeutic peptides that uniquely target adiponectin signaling pathways. Adiponectin, a natural protein whose receptors are widely distributed, has multiple beneficial actions, including anti-inflammatory, anti-fibrotic, anti-steatotic, and cell regenerative properties; it also plays a critical role in maintaining metabolic energy balance at the cellular and organism level and reverses insulin resistance.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Allysta PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    400 Concar Drive San Mateo, CA 94402
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.allysta.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Allysta Pharma Announces Completion of Enrollment in Ph2b/3 Trial (OASIS-1)
    Allysta Pharma Announces Completion of Enrollment in Ph2b/3 Trial (OASIS-1)

    08 Nov 2022

    // ACCESSWIRE

    https://www.accesswire.com/724555/Allysta-Pharmaceuticals-Inc-Announces-Completion-of-Enrollment-in-Phase-2b3-Clinical-Trial-OASIS-1-Evaluating-the-Efficacy-and-Safety-of-ALY688-Ophthalmic-Solution-in-Dry-Eye-Disease

    ACCESSWIRE
    08 Nov 2022
    Share Share
    Allysta Announces Initiation of Dosing in OASIS-1 Phase 2b/3 Clinical Trial
    Allysta Announces Initiation of Dosing in OASIS-1 Phase 2b/3 Clinical Trial

    22 Jun 2021

    // ACCESSWIRE

    https://www.accesswire.com/652578/Allysta-Pharmaceuticals-Inc-Announces-Initiation-of-Dosing-in-OASIS-1-Phase-2b3-Clinical-Trial-ALY688-301-Study-Evaluating-the-Efficacy-and-Safety-of-ALY688-Ophthalmic-Solution-in-Dry-Eye

    ACCESSWIRE
    22 Jun 2021
    Share Share
    Allysta Pharma Announces Start of Phase 1 Clinical Trial of ALY688-SR
    Allysta Pharma Announces Start of Phase 1 Clinical Trial of ALY688-SR

    10 Jun 2021

    // ACCESSWIRE

    https://www.accesswire.com/651136/Allysta-Pharmaceuticals-Inc-Announces-Start-of-Phase-1-Clinical-Trial-of-ALY688-SR-a-Novel-First-in-Class-Peptide-that-Targets-Adiponectin-Signaling

    ACCESSWIRE
    10 Jun 2021
    Share Share
    Allysta Pharmaceuticals, Inc. Announces Positive Preclinical Data
    Allysta Pharmaceuticals, Inc. Announces Positive Preclinical Data

    16 Dec 2020

    // ACCESSWIRE

    https://www.accesswire.com/620848/Allysta-Pharmaceuticals-Inc-Announces-Positive-Preclinical-Data-in-a-NASH-Model-Demonstrating-its-Adiponectin-Analogue-ALY688-Reduces-Liver-Fat-Inflammation-and-Fibrosis

    ACCESSWIRE
    16 Dec 2020
    Share Share
    Allysta nnounces Positive Results from its Phase 1/2a Clinical Trial of ALY688
    Allysta nnounces Positive Results from its Phase 1/2a Clinical Trial of ALY688

    01 Dec 2020

    // ACCESSWIRE

    https://www.accesswire.com/618835/Allysta-Pharmaceuticals-Inc-Announces-Positive-Results-from-its-Phase-12a-Clinical-Trial-of-ALY688-Ophthalmic-Solution-in-Dry-Eye-Disease

    ACCESSWIRE
    01 Dec 2020
    Share Share
    Allysta Pharmaceuticals, Inc. Doses First Patient with ALY688 Solution
    Allysta Pharmaceuticals, Inc. Doses First Patient with ALY688 Solution

    08 Jan 2020

    // PRESS RELEASE

    https://www.accesswire.com/viewarticle.aspx?id=572365&lang=English

    PRESS RELEASE
    08 Jan 2020
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search